New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
06:45 EDTALNY
theflyonthewall.com: Alnylam Pharm downgraded to Hold from Buy at Roth Capital
Roth Capital downgraded Alnylam due to the slowing of developmental progress in its lead drug, ALN-RSV01. :theflyonthewall.com



News For ALNY From The Last 14 Days
Check below for free stories on ALNY the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 8, 2010
08:13 EDTALNY
theflyonthewall.com: Alnylam awarded a Notice of Allowance for the Soutschek and Manoharan patent
Alnylam Pharmaceuticals announced that the United States Patent and Trademark Office has awarded a Notice of Allowance for the “Soutschek and Manoharan” patent, which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery. The new patent is based on the ground-breaking research by Alnylam scientists on systemic delivery of RNAi therapeutics as documented in Soutschek et al. :theflyonthewall.com